1. bookVolume 21 (2013): Issue 1 (March 2013)
Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Evaluation of serum hepcidin variation in patients with rheumatoid arthritis according to anemia profile and its correlation with disease activity

Published Online: 08 Aug 2013
Volume & Issue: Volume 21 (2013) - Issue 1 (March 2013)
Page range: 17 - 27
Journal Details
License
Format
Journal
eISSN
2284-5623
ISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Objective: The objectives of this study were: determination of serum hepcidin levels in patients with Rheumatoid arthritis (RA) with/without anemia and controls, and its correlation with disease activity and anemia parameters. Patients and Methods: 69 people were involved in our study: 54 patients and 15 healthy subjects (controls). Laboratory evaluation of anemia, iron parameters, serum hepcidin levels and disease activity was carried out. RA patients were divided in two groups: anemic group and non-anemic group (NA), according to hemoglobin levels (Hb). Soluble transferrin receptor-ferritin index (sTfR-F index) was used to classify anemia types: anemia of chronic disease (ACD) and anemia of chronic disease + iron deficiency anemia (ACD+IDA). Disease activity was evaluated using the following parameters: erythrocyte sedimentation rate (ESR), C-reactive protein (CPR), and disease activity score (DAS28). Results: ACD and ACD+IDA groups had significantly higher serum hepcidin concentrations than controls (p<0.001, p<0.001), and NA group (p=0.006, p=0.002). No difference in hepcidin levels was observed between ACD and ADC+IDA groups (p=0.85) and between NA and controls (p=0.66). ESR was significantly higher in ACD and ACD+IDA groups compared with NA group (p<0.001, p=0.002) and controls. (p<0.001, p<0.001).DAS 28 score was higher in anemic groups than NA group (ACD vs. NA, p=0.01), (ACD+IDA vs. NA, p=0.01) and no difference was observed between ACD and ACD+IDA In RA patients serum hepcidin concentration was significantly negatively correlated with hemoglobin (Hb) (r= -0.459, p<0.000) and serum iron( r=-0.357, p<0.01) and positively with disease activity variables: ESR (r=0.352, p<0.01) , CRP (r=0.369, p<0.01), DAS28 score (r=0.289, p<0.05). Conclusion: Hepcidin increases in RA patients with anemia and its levels correlate with Hb, serum iron, and disease activity variables.

Keywords

Cuvinte cheie

1. Wilson A, Yu HT, Goodnough LT, Nissenson AR. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004; 116 (Suppl 7A):50S-7S10.1016/j.amjmed.2003.12.01215050886Search in Google Scholar

2. Skikne B S, Punnonen K, Caldron P.H, Bennett M.T, Rehu M, Gasior G.H.et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index Am J Hematol.2011;86 (11):923-27.Search in Google Scholar

3. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352: 1011-2310.1056/NEJMra04180915758012Search in Google Scholar

4. Bloxham E, Vagadia V, Scott K, Francis G, Saravanan V, Heycocket C, et al. Anemia in rheumatoid arthritis: can we afford to ignore it? Postgrad Med J. 2001; 87: 596-600.Search in Google Scholar

5. Zhang X , Rovin BH, Biol Chem Beyond anemia:hepcidin, monocytes and inflammation.2013 ; 394(2):231-8.10.1515/hsz-2012-021723314535Search in Google Scholar

6. Piperno A, Mariani R, Trombini P , Girelli D. Hepcidin modulation in human diseases: From research to clinic World J Gastroenterol.2009 ;15(5): 538-551.Search in Google Scholar

7. Swinkels DW, J F M Wetzel Hepcidin: a new tool in the management of anemia in patients with chronic kidney disease? Clinical Chem . 2002, ; 48(7):1066-76.Search in Google Scholar

8. Kemna EHJM, Tjalsma H, Podust NV, Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007; 53: 620-8.10.1373/clinchem.2006.07918617272487Search in Google Scholar

9. Ganz T Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages. Best Practice & Research Clinical Haematology. 2005, 18(2):171-182.10.1016/j.beha.2004.08.02015737883Search in Google Scholar

10. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002 ; 110 : 1037-44.10.1172/JCI0215686Search in Google Scholar

11. Wrighting D M, Andrews N C. Interleukin-6 induces hepcidin expression through STAT3.Blood , 2006; 108 ( 9).3204-9.10.1182/blood-2006-06-027631189552816835372Search in Google Scholar

12. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101 : 2461-3.10.1182/blood-2002-10-323512433676Search in Google Scholar

13. Tomas Ganz. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood . 2003 102 (3) 783-788.10.1182/blood-2003-03-067212663437Search in Google Scholar

14. Patiu M, Lazlo G Review Iron metabolism disorder exploration .Classical and modern .Studia Universitatis Babes-Bolyai.Biologia.2007.LII.2:83-92.Search in Google Scholar

15. Hebbar A Kesh, Gibson M V.Patient Care. Nov 2006:36-37 www.patientcareonline.10.1097/00006247-200607000-00008Search in Google Scholar

16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum.1988; 31 : 315-24.10.1002/art.17803103023358796Search in Google Scholar

17. Report of a WHO Scientific Group. Nutritional Anemias. World Health Organization, Geneva, 1968Search in Google Scholar

18. Rimon E, Levy S, Sapir A. Diagnosis of iron deficiency anemia in elderly by transferrin receptor- ferritin index. Arch Intern Med. 2002 ; 162 : 445-9.10.1001/archinte.162.4.44511863478Search in Google Scholar

19. Choi CW, Cho W R, Park K H, Choi I K , Seo J H, Kim B S et all The cutoff value of serum ferritin for the diagnosis of iron deficiency in community-residing older persons. Annals of Hematology 2005; 84(6): 358-61.10.1007/s00277-005-1033-515789229Search in Google Scholar

20. Thomas L, Thomas C. Anemia in iron deficiency and disorders of iron metabolism. Deutsch Med Wochenschr.2002; 127 : 1591-4.10.1055/s-2002-3293612143015Search in Google Scholar

21. Margetic S, Topic E, Ruzic DF, Kvaternik M, et al. Soluble transferring receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis. Clin Chem Lab Med.2005 ; 43: 326-31.10.1515/CCLM.2005.05615843240Search in Google Scholar

22. Kogan A, Filatov V, Gusev N, Bereznikova A, Kolosova O, Katrukha A, et al. Immunological study of complex formation between soluble transferrin receptor and transferring. Am J Hematol.2005 ; 79 : 281-7.10.1002/ajh.2042916044455Search in Google Scholar

23. Shilpa J, Shashi N, Jagdish C, Sunita S, Sonal J, Priya M, et al. Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease. Indian J Pediatr. 2010 ; 77 : 179-8310.1007/s12098-009-0302-z20091370Search in Google Scholar

24. Goyal R, Das R, Bambery P, Garewal G. Serum transferrin receptor ferritin index shows concomitant iron deficiency anemia and anemia of chronic disease is common in patients with rheumatoid arthritis in north India. Indian J Pathol Microbiol. 2008; 51(1) : 102-4.10.4103/0377-4929.4041718417876Search in Google Scholar

25. Yamanishi H, Iyama S, Yamaguchi Y, Kanakura Y, Iwatani Y. Total iron binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron binding capacity. Clin Chem. 2003; 49 : 175-8.10.1373/49.1.17512507977Search in Google Scholar

26. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002 ;48: 1066-76.10.1093/clinchem/48.7.1066Search in Google Scholar

27. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LN, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis &Rheum. 1995; 38 : 44-8.10.1002/art.1780380107Search in Google Scholar

28. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide- bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000; 480: 147-50.10.1016/S0014-5793(00)01920-7Search in Google Scholar

29. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001; 276: 7806-10.10.1074/jbc.M00892220011113131Search in Google Scholar

30. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci. 2001; 98: 8780-5.10.1073/pnas.1511794983751211447267Search in Google Scholar

31. Koca SS, Isik A, Ustundag B, Metin K, Aksoy K. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation 2008; 31: 146-53.10.1007/s10753-008-9060-818278547Search in Google Scholar

32. Kim HR, Kim KW,Yoon SJ, Kim SH, Lee SH. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis. J Korean Med Sci. 2010; 25 : 348-5210.3346/jkms.2010.25.3.348282673320191031Search in Google Scholar

33. Dallalio G, Fleury T, Means Jr RT. Serum hepcidin in clinical specimens. Br J Haematol. 2003;122: 996-1000.10.1046/j.1365-2141.2003.04516.x12956771Search in Google Scholar

34. Roe MA, Collings R, Dainty JR, Swinkels DW, Fair- weather-Tait SJ. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr. 2009; 89: 1088-91.10.3945/ajcn.2008.2729719211819Search in Google Scholar

35. Deicher R, , HÖrl W H. Hepcidin: a molecular link between inflammation and anemia. Nephrol Dial Transplant 2004 Mar; 19 (3):521-4.10.1093/ndt/gfg56014767000Search in Google Scholar

36. Cheng P P, Jiao X-Y, , Wang X-h, Lin J h, Cai Ying-m Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia Clinical and Experimental Medicine. 2010; 11(1):33-42.10.1007/s10238-010-0102-920499129Search in Google Scholar

37. van Santen S, van Dongen-Lases EC, de Vegt F, Laarakkers CMM, van Riel PLCM, van Ede AE, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis & Rheum. 2011;63: 3672-80.10.1002/art.3062322127690Search in Google Scholar

38. Kroot JJC, Kemna EHJM, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009;94: 1748-52.10.3324/haematol.2009.010322279195019996119Search in Google Scholar

39. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008; 112 :4292-7.10.1182/blood-2008-02-13991518689548Search in Google Scholar

40. Ganz T, Nemeth E. Hepcidin and disordersof iron metabolism. Annu Rev Med. 2011; 62 :347-60. 10.1146/annurev-med-050109-14244420887198Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo